Irma Alvarez-Horwith, NP
Payments from drug & device makers
Across 203 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$806
- AbbVie$561
- Collegium Pharmaceutical, Inc.$500
- Scilex Pharmaceuticals Inc.$372
- Biohaven Pharmaceuticals, Inc.$317
- Zynex Medical, Inc.$247
- plus $991 from 16 others
Across 14 payments — averaging $169.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
What the payments were for
- Food & beverage$3,793100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 56 | $806 |
| AbbVie(2 entities) | 31 | $561 |
| Collegium Pharmaceutical, Inc. | 28 | $500 |
| Scilex Pharmaceuticals Inc. | 18 | $372 |
| Biohaven Pharmaceuticals, Inc. | 18 | $317 |
| Zynex Medical, Inc. | 1 | $247 |
| Redhill Biopharma Inc. | 9 | $190 |
| Azurity Pharmaceuticals, Inc. | 7 | $145 |
| Idorsia Pharmaceuticals US Inc | 6 | $118 |
| Lilly USA, LLC | 6 | $107 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Eisai Inc. | 3 | $58 |
| Vertex | 2 | $44 |
| GRT US Holding, Inc. | 2 | $34 |
| Pfizer | 2 | $33 |
| Medtronic | 2 | $30 |
| Tersera Therapeutics LLC | 1 | $19 |
| Boston Scientific | 1 | $17 |
| Relievant Medsystems, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| USWM, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nexwave$247
How this compares
$3,793 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 24 | $43,174 |
| Nurtec OdtRimegepant Sulfate | 13 | $25,560 |
| ZtlidoLidocaine | 26 | $19,320 |
| MovantikNaloxegol Oxalate | 31 | $16,275 |
| Lidocaine | 59 | $7,958 |
| Diclofenac Sodium | 81 | $3,545 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 73 | $1,984 |
| Cyclobenzaprine Hcl | 173 | $1,865 |
| Tizanidine Hcl | 119 | $1,822 |
| Gabapentin | 147 | $1,638 |
| Desipramine Hcl | 14 | $693 |
| Trazodone Hcl | 111 | $683 |
| Ondansetron OdtOndansetron | 38 | $670 |
| Ibuprofen | 75 | $615 |
| Baclofen | 40 | $596 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $806 | $43,17424 claims |
| PfizerNurtec Odt | $33 | $25,56013 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $372 | $19,32026 claims |
| Redhill Biopharma Inc.Movantik | $190 | $16,27531 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Tampa
- Lewis HarringtonTampa$954K
- Natasha WickTampa$126K
- Marie Labadie-DegennaroTampa$66K
- Polly BittleTampa$63K
- Katharine WilliamsTampa$47K
- Candace DeberryTampa$46K
- Bailey BlankenshipTampa$42K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.